Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005339694 | SCV006007002 | uncertain significance | not specified | 2025-01-21 | criteria provided, single submitter | clinical testing | The c.1331C>T (p.S444L) alteration is located in exon 12 (coding exon 11) of the FNDC3A gene. This alteration results from a C to T substitution at nucleotide position 1331, causing the serine (S) at amino acid position 444 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |